ABK Biomedical announces FDA 510(k) clearance of Easi-Vue™ embolic microspheres for the embolization of arteriovenous malformations and hypervascular tumors ...Middle East

HALIFAX, NS, Sept. 12, 2022 /PRNewswire/ - ABK Biomedical, Inc., an innovative medical device company dedicated to the research, development, and commercialization of advanced imageable embolic therapies, announces FDA 510(k) clearance of Easi-Vue embolic microspheres for the treatment of...

Hence then, the article about abk biomedical announces fda 510 k clearance of easi vue embolic microspheres for the embolization of arteriovenous malformations and hypervascular tumors was published today ( Monday 12/09/2022 - 04:32 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ABK Biomedical announces FDA 510(k) clearance of Easi-Vue™ embolic microspheres for the embolization of arteriovenous malformations and hypervascular tumors )

Also on site :

• 1977 Blockbuster Film, Which Produced 4 No. 1 Hit Songs, Is Ranked One of the Best Soundtracks of All Time
• Donald Trump hints he’ll run for president again at White House correspondents’ dinner: ‘I’m gonna do it’
• Costco's New Feel-Good Freezer Find Puts a Fresh Spin on Breakfast